Gabit is a wearable health startup based in Gurugram, India, that sells a titanium smart ring with an AI coaching app, and is expanding into nutrition and skincare, for health-conscious consumers.

This Startup Deep Dive explains what Gabit does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Gabit in Brief

• What it is: Gabit is an Indian Smart ring wearables company based in Gurugram.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Gabit (short for 'Good Habit') sells a titanium smart ring that tracks over 150 health markers, with heart rate, SpO2, sleep and steps, about 7 days of battery and no subscription fee.
• The ring was priced around Rs 13,900-14,500 in India and has been available since about January 2025 (reported).
• An AI companion app offers coaching, FitBot (AI fitness coach), SkinBot (skin analysis) and small user groups called Gabins.
• Funding: Over $12.7 million (reported), excluding an undisclosed round from Ranbir Kapoor and Badshah.

Gabit Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Gabit?

Gabit operates in the Smart ring wearables space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Gabit.

• Gabit (short for 'Good Habit') sells a titanium smart ring that tracks over 150 health markers, with heart rate, SpO2, sleep and steps, about 7 days of battery and no subscription fee.
• The ring was priced around Rs 13,900-14,500 in India and has been available since about January 2025 (reported).
• An AI companion app offers coaching, FitBot (AI fitness coach), SkinBot (skin analysis) and small user groups called Gabins.
• It is expanding into personalised nutrition and skincare (sunscreens, serums, facewash, moisturisers).

The Origin Story of Gabit

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Gaurav Gupta, Arpana Shahi.
• Founded in 2022 by husband-and-wife duo Gaurav Gupta, a former Zomato co-founder, and Arpana Shahi, who previously founded SkillTap.
• Gupta said his interest in health grew during the pandemic after improving his nutrition, fitness, sleep and skin habits; he announced Gabit on X on 19 January 2024 after a stealth period.
• HQ reports differ: most say Gurugram, one says Bengaluru.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Smart ring wearables sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• Early 2023: $9.5 million seed raised in stealth.
• 19 January 2024: Gabit publicly announced.
• Around January 2025: smart ring on sale in India.
• 2025: Ranbir Kapoor and Badshah invested (amount undisclosed).
• December 2025: acquired Sweden-based nutrition brand Nack.
• March-April (2026 implied by the report): about Rs 36.2 crore raised from angels.

Gabit Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Early 2023: $9.5 million seed from Norwest Venture Partners, Deepinder Goyal, Kunal Shah and Amit Agarwal; named angels include Vikram Chopra, Akshant Goyal and Mohit Gupta.
• 2025: undisclosed round from Ranbir Kapoor and Badshah, excluded from totals.
• Rs 36.2 crore in two pre-Series A5 convertible preference share tranches from angels including Deepak Gupta, Arnab Basu, Manav Gupta and Vilas Dhar; the round appears ongoing.

How Does Gabit Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Direct-to-consumer hardware: smart ring sold without a subscription, with revenue from ring sales.
• Cross-sell of nutrition supplements (boosted by the Nack acquisition) and skincare products through the app and coaching.
• Celebrity nutritionists, fitness coaches and dermatologists onboarded to drive engagement (company-stated).

The Numbers: Gabit Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• No revenue or profit figures were found.
• Total funding above $12.7 million (reported).

Market Opportunity for Gabit

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Gabit targets health-conscious Indian consumers in the fast-growing smart ring and D2C health segment.
• Priced below Ultrahuman Ring Air (about Rs 28,499) and Noise Luna Ring (about Rs 23,999) in listings.

Technology and Product at Gabit

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Titanium smart ring with sensors for heart rate, SpO2, sleep and activity, water resistant to 50 m.
• AI coaching app; reviewers noted missing sync with Apple Health and Google Fit.

Team and Culture at Gabit

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Co-founders Gaurav Gupta (ex-Zomato co-founder) and Arpana Shahi (ex-SkillTap founder).
• Backed by prominent angels including Deepinder Goyal and Kunal Shah.

Gabit Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Gabit

• Sources disagree on founding year, HQ and earlier funding totals.
• No revenue data; hardware margins and competition from Ultrahuman and Noise are unclear.
• Reviewers flagged missing data sync with Apple Health and Google Fit and an overwhelming app.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Gabit Growth Outlook: What to Watch

• Funds are aimed at expanding wearables, nutrition and skincare.
• The Nack acquisition signals a push into supplements and international brands.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Gabit can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Gabit Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Gabit

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Gabit.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Gabit

Studying a company in the Smart ring wearables space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Gabit.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Gabit as a Startup

• Customer clarity: Can Gabit name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Gabit is part of India’s growing Smart ring wearables ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Gabit FAQs: Frequently Asked Questions

What is Gabit?

Gabit is a wearable health startup based in Gurugram, India, that sells a titanium smart ring with an AI coaching app, and is expanding into nutrition and skincare, for health-conscious consumers. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Gabit?

Gabit was founded by Gaurav Gupta, Arpana Shahi, and the company reports a founding year of 2022 (publicly announced January 2024; one database says 2023).

How much funding has Gabit raised?

Over $12.7 million (reported), excluding an undisclosed round from Ranbir Kapoor and Badshah. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Gabit make money?

Gabit earns revenue from its Smart ring wearables products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Gabit?

Reported rivals include Ultrahuman, Noise, boAt, Muse Wearables. See the competitor comparison above for how they differ.

What are the main risks for Gabit?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Vrisva Space — short profile of what is publicly known | Dhan — Dhan became a unicorn with a reported $120M Series B. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.